Back

Pacific Biosciences of California Quote, Financials, Valuation and Earnings

MarketBeat Alert: Escape the market madness with 7 stocks to buy and hold

The result is a select group of high-quality blue-chip stocks.

Sell

PACB
Pacific Biosciences of California

Last Price:

1.47

Seasonality Move:

-2.4%

7 Day Trial

ALL ACCESS PASS

$ 7

Will Crypto Make People Rich Again Starting April 2024?

Details on how to profit here.

Pacific Biosciences of California Price Quote

$1.47

+0.07 (+5%)

(Updated: April 18, 2024 at 6:55 PM ET)

Pacific Biosciences of California Key Stats

Sell

Pacific Biosciences of California (PACB) is a Sell

Day range:

$1.25 - $1.52

52-week range:

$1.36 - $14.55

Dividend yield:

P/E ratio:

0.00

P/S ratio:

1.77

P/B ratio:

0.53%

Volume:

34.4M

Avg. volume:

10.6M

1-year change:

-87.28%

Market cap:

$375.1M

Revenue:

$200.5M

EPS:

$-1.21

How Much Does Pacific Biosciences of California Make?

How Much Are Pacific Biosciences of California's Sales Annually?
PACB Revenues are $200.5M
How Much Profit Does Pacific Biosciences of California's Make A Year?
PACB net income is -$306.7M

Is Pacific Biosciences of California Growing As A Company?

What Is Pacific Biosciences of California's Growth Rate Quarterly?
Quarterly YoY revenue growth is 1.13%
What Is Pacific Biosciences of California's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%

Pacific Biosciences of California Stock Price Performance

Did Pacific Biosciences of California Stock Go Up Last Month?
Pacific Biosciences of California share price went down by -63.06% last month
Did PACB's Share Price Rise Over The Last Year?
PACB share price fell by -87.28% over the past 1 year

What Is Pacific Biosciences of California 52-Week High & Low?

What Is Pacific Biosciences of California’s 52-Week High Share Price?
Pacific Biosciences of California has traded as high as $14.55 over the past 52 weeks
What Is Pacific Biosciences of California’s 52-Week Low Share Price?
Pacific Biosciences of California has traded as low as $1.36 over the past 52 weeks

Pacific Biosciences of California Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Pacific Biosciences of California?

How Much Debt Does Pacific Biosciences of California Have?
Total long term debt quarterly is $892.7M
How Much Cash Does Pacific Biosciences of California Have?
Cash and short term investments quarterly total is $631.4M
What Is Pacific Biosciences of California’s Book Value Per Share?
Book value per share is 2.62

Is Pacific Biosciences of California Cash Flow Positive?

What Is PACB Cash Flow From Operations?
Cash flow from operations (TTM) is -$259.2M
What Is Pacific Biosciences of California’s Cash Flow From Financing?
Cash flow from financing (TTM) is $108.9M
What Is Pacific Biosciences of California’s Cash Flow From Investing?
Cash flow from investing (TTM) is $4.6M

Pacific Biosciences of California Return On Invested Capital

Is Management Doing A Good Job?
PACB return on invested capital is -19.58%
What Is Pacific Biosciences of California Return On Assets?
ROA measures how assets are converting to revenues and is -16.75%
What Is PACB Return On Equity?
ROE is a measure of profitability and is -45.62%

Pacific Biosciences of California Earnings Date & Stock Price

What Is Pacific Biosciences of California's Stock Price Today?
A single share of PACB can be purchased today for 1.40
What Is Pacific Biosciences of California’s Stock Symbol?
Pacific Biosciences of California trades on the nasdaq under the ticker symbol: PACB
When Is Pacific Biosciences of California’s Next Earnings Date?
The next quarterly earnings date for Pacific Biosciences of California is scheduled on May 2, 2024
When Is PACB's next ex-dividend date?
Pacific Biosciences of California's next ex-dividend date is April 19, 2024
How To Buy Pacific Biosciences of California Stock?
You can buy Pacific Biosciences of California shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Pacific Biosciences of California Competitors

Who Are Pacific Biosciences of California's Competitors?
Below is a list of companies who compete with Pacific Biosciences of California or are related in some way:
- Axogen Inc (AXGN)
- Cerus Corp (CERS)
- Integer Holdings Corp (ITGR)
- Intellia Therapeutics Inc (NTLA)
- AVITA Medical Inc (RCEL)

Pacific Biosciences of California Dividend Yield